Author:
Tülümen Erol,Borggrefe Martin
Publisher
Springer International Publishing
Reference18 articles.
1. Thomas Michel BH. Calcium channel antagonists. In: Knollman LBBCB, editor. Goodman & Gilman’s the pharmacological basisi of therapeutics. 12th ed. New York: McGraw Hill; 2011. p. 755–60.
2. Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2016;133(14):e471–505.
3. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20.
4. Fabiato A. Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am J Phys. 1983;245(1):C1–14.
5. Milberg P, Fink M, Pott C, Frommeyer G, Biertz J, Osada N, et al. Blockade of I(Ca) suppresses early afterdepolarizations and reduces transmural dispersion of repolarization in a whole heart model of chronic heart failure. Br J Pharmacol. 2012;166(2):557–68.